Oral misoprostol vs vaginal misoprostol
Oral misoprostol may leads to higher oxytocin augmentation compared with vaginal misoprostol (low certainty).
- RR 1.28 [1.15, 1.44]28 studies · 5416 participantsLow
Oral misoprostol may leads to higher oxytocin augmentation compared with vaginal misoprostol (low certainty).
It is very uncertain whether oral misoprostol one‐ to two‐hourly changes oxytocin augmentation compared with oral misoprostol four‐ to six‐hourly (very low certainty).
Oral misoprostol may leads to lower oxytocin augmentation compared with intravenous oxytocin (low certainty).
Oral misoprostol may leads to lower oxytocin augmentation compared with mechanical methods (low certainty).
Oral misoprostol probably leads to lower oxytocin augmentation compared with placebo/no treatment (moderate certainty).
It is very uncertain whether oral misoprostol changes oxytocin augmentation compared with vaginal dinoprostone (very low certainty).
It is very uncertain whether oral misoprostol 20 µg hourly titrated changes oxytocin augmentation compared with oral misoprostol 25 µg two‐hourly static (very low certainty).